Evidence map›Paper›PMID 35106398›Full record

ReviewHealth psychology research2021

The Role of Vitamin D in the Management of Chronic Pain in Fibromyalgia: A Narrative Review.

Hannah W Haddad, Allison C Jumonville, Katarina J Stark, Shavonne N Temple, Chukwudum C Dike, Elyse M Cornett, Alan D Kaye

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Health psychology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Hannah W HaddadKansas City University of Medicine and Biosciences, Kansas City, MO.
Allison C JumonvilleLouisiana State University Health Shreveport, LA.
Katarina J StarkMedical College of Wisconsin, Wauwatosa, WI.
Shavonne N TempleLouisiana State University Health Shreveport, LA.
Chukwudum C DikeUniversity of Medicine and Health Sciences St. Kitts, Camps, Basseterre, St. Kitts.
Elyse M CornettDepartment of Anesthesiology, Louisiana State University Health Shreveport, LA.
Alan D KayeDepartment of Anesthesology, Louisiana State University Health Shreveport, LA.
Louisiana State University · USKansas City University · USLouisiana State University in Shreveport · USMedical College of Wisconsin · USRoss University School of Veterinary Medicine · KN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFibromyalgia (FM) is a complex disorder characterized primarily by chronic, widespread musculoskeletal pain. Currently, the Food and Drug Administration (FDA) has approved the use of three medications to treat FM: pregabalin, duloxetine, and milnacipran. The pharmaceutical intervention has lacked consistent pain relief among all patients. Therefore, the investigation into alternative treatment options has grown in interest. This narrative review aims to evaluate the evidence regarding vitamin D for the treatment of FM.

methodsNarrative review.

resultsLow serum vitamin D has been linked to various chronic pain states. An association between vitamin D deficiency and FM has been reported but is controversial in the literature. Some studies have documented the beneficial effects of vitamin D supplementation on reducing pain symptoms and improving the overall quality of life in those with FM. Despite these positive findings, many of the studies regarding this topic lack adequate power to make substantial conclusions about the effects of vitamin D on FM.

conclusionExisting studies provide promising results. However, additional high-quality data on vitamin D supplementation is needed before recommendations for pain management can be made. Vitamin D supplementation is inexpensive, has minimal side effects, and can benefit FM patients regardless of its efficacy in pain control. Additionally, high-quality studies are warranted to fully elucidate the potential of vitamin D to manage chronic pain in FM.

Indexed as

chronic painfibromyalgiasupplementationvitamin d

Identifiers

PMID35106398
PMCPMC8801481
OpenAlexW3181103207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.